Cytori Therapeutics to Present at the BIOCOM Investor Conference.SAN DIEGO -- Cytori Therapeutics, Inc., (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CYTX) (Frankfurt: XMPA XMPA X-ray Electron Microprobe Analysis XMPA Extensible Media Protection Architecture ) announced today that it will present and provide an audio webcast of its corporate presentation at the BIOCOM Investor Conference, November 15th at 3:40 p.m. Pacific Standard Time (6:40 p.m. Eastern Standard Time). A webcast of the presentation may be accessed under "Events & Webcasts" in the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of the Company's website at http://www.cytoritx.com. The webcast will be available live and by replay one hour after the presentation on the company's website and archived for 30 days. About Cytori Therapeutics Cytori Therapeutics, Inc., (NASDAQ: CYTX) (Frankfurt: XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue adipose tissue (ăd`əpōs'): see connective tissue. adipose tissue or fatty tissue Connective tissue consisting mainly of fat cells, specialized to synthesize and contain large globules of fat, within a , also known as fat. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose adipose /ad·i·pose/ (ad´i-pos) 1. fatty. 2. the fat present in the cells of adipose tissue. ad·i·pose adj. Of, relating to, or composed of animal fat; fatty. stem and regenerative cells, Cytori has developed its proprietary Celution[TM] System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion